問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Tri-Service General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2025-10-01 - 2035-01-20
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting6Sites
2022-08-01 - 2027-12-31
Participate Sites8Sites
Recruiting8Sites
2020-04-01 - 2026-09-01
Participate Sites4Sites
Recruiting4Sites
2024-08-26 - 2026-07-23
Participate Sites7Sites
Recruiting7Sites
2016-12-01 - 2021-03-22
Participate Sites5Sites
Recruiting5Sites
2022-09-01 - 2024-12-31
Participate Sites12Sites
Not yet recruiting1Sites
Recruiting10Sites
2003-11-01 -
Participate Sites3Sites
Recruiting3Sites
2024-03-01 - 2026-03-31
2020-01-03 - 2021-03-08
AR-301 as Adjunct Therapy to Antibiotics in the Treatment of Ventilator-associated Pneumonia (VAP) Caused by S. aureus
AR-301 Tosatoxumab
Participate Sites10Sites
Not yet recruiting9Sites
Recruiting1Sites
2020-11-30 - 2021-12-31
Participate Sites1Sites
全部
